[Therapy for hormone-refractory prostate cancer]

MeSH terms

• Androgens*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Bone Neoplasms / drug therapy
• Bone Neoplasms / radiotherapy
• Bone Neoplasms / secondary
• Clinical Trials as Topic
• Clodronic Acid / therapeutic use
• Cyclophosphamide / administration & dosage
• Dexamethasone / administration & dosage
• Dexamethasone / therapeutic use
• Docetaxel
• Estramustine / administration & dosage
• Humans
• Male
• Neoplasms, Hormone-Dependent / drug therapy*
• Neoplasms, Hormone-Dependent / pathology
• Neoplasms, Hormone-Dependent / radiotherapy
• Paclitaxel / administration & dosage
• Paclitaxel / analogs & derivatives*
• Prostatic Neoplasms / drug therapy*
• Prostatic Neoplasms / pathology
• Prostatic Neoplasms / radiotherapy
• Strontium Radioisotopes / therapeutic use
• Taxoids*
• Tegafur / administration & dosage
• Treatment Outcome